Abstract: Starting from estrone, 3-benzyloxy-17-hydroxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (1) was synthesized in several synthetic steps. This compound was the key intermediate in the syntheses of other 17-substituted-16,17-secoestrone derivatives. Among them, 3-hydroxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (5) is of special interest, because of its antiestrogenic activity, with no estrogenic properties. For this reason an alternative pathway for the synthesis of this compound was sought. The structures of 3-benzyloxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (compound 2) and 3-hydroxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (compound 4), intermediates in the two different synthetic pathways used to obtain the desired compound 5, were unambiguously proved by appropriate X-ray structural analyses. The puckering, asymmetry parameters and torsion angles of compounds 2 and 4 are discussed and molecular-mechanic calculations for them were performed.
INTRODUCTION
Since estrogens are known to play a significant role in the development of breast cancer, a logical approach to the treatment of this estrogen-dependent disease is the use of antiestrogens which block the interaction of estrogens with their specific receptors. 1 Antiestrogens might also be useful in treating a variety of non-malignant estrogen-dependent diseases, such as endometriosis. 2 Previously a series of 3-hydroxy-16,17-secoestrone derivatives were synthesized, which in in vivo biological experiments showed an almost complete loss of estrogenic activity, while most of them demonstrated a pronounced antiestrogenic action. [3] [4] [5] [6] Among them, one of the most potent derivatives was 3-hydroxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (5). 5 Two alternative routes for the synthesis of this biologically active compound were thought out. The first of them was published earlier, 3 while the second pathway is presented here. The intermediates from both syntheses were identified on the basis of NMR spectra. Additionally, the structures of the derivatives 2 and 4 were unambiguously confirmed by X-ray studies.
EXPERIMENTAL

Synthesis and characterization
Melting points were determined in open capillary tubes using a Büchi SMP 20 apparatus and are uncorrected. Proton NMR-spectra were recorded on a Bruker AC 250E spectrometer operating at 250 MHz using standard Bruker software. The signals are reported in parts per million downfield from tetramethylsilane as internal standard (d 0.00); symbols s, d, dd and m denote singlet, doublet, double doublet and multiplet, respectively. All reagents used were analytical-grade, commercially available substances. 6 To a solution of 3-benzyloxy-17-hydroxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (1, 1 g, 2.66 mmol) in absolute pyridine (28 cm 3 ), p-toluenesulphonyl chloride (1.7 g, 8.8 mmol) was added and the mixture was kept at room temperature for 50 h. After completion of the reaction, the resulting solution was poured into dilute HCl (1:1, 200 cm 3 ), the protuct was filtered off, washed with water until neutral and air-dried to give 1.32 g (93 %) of pure 3-benzyloxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (3) in the form of an amorphous mass. 1 
3-Benzyloxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (3)
3-Hydroxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (4)
To a solution of 3-benzyloxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (3, 1 g, 1.9 mmol) in acetone-ethanol mixture (1:1, 60 cm 3 ), 10 % Pd/C as catalyst (0.344 g) was added. The suspension was stirred at room temperature for 10 h under an atmosphere of hydrogen. After removal of the catalyst, the solvent was evaporated to dryness and the crude product (0.72 g) was purified by column chromatography on silica gel (55 g, benzene), yielding 0.708 g (86 %) of 3-hydroxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5 (10) (5) 3-Hydroxy-17-p-toluenesulphonyloxy-16,17-secoestra-1,3,5(10)-triene-16-nitrile (4, 1 g, 2.28 mmol) was dissolved in ethyl methyl ketone (100 cm 3 ) and tetrabutylammonium bromide (5.2 g, 16 mmol) was added. The reaction mixture was intensively stirred at reflux temperature for 120 h, then poured into ice-cold water and the resulting emulsion was extracted with diethyl ether (5´30 cm 3 ). The collected extracts were dried over anhydrous sodium sulphate and evaporated to dryness. The crude product (0.75 g) was purified by column chromatography on silica gel (75 g, benzene), whereby, after recrystallization from benzene-diethyl ether, pure 3-hydroxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile ( 
X-ray studies
The diffraction data were collected using a Siemens P4 diffractometer and the structures were solved by SHELXS-86 7 and refined by SHELXL-97. 8 The crystallographic data of the compound 2 (Table I) have been deposited at the Cambridge Crystallographic Data Centre (CCDC 205268).
On the other hand, the structure of the derivative 4 was solved with uncompleted data and partially unisotropically refined to R 1 = 0.103. Namely, after collecting about 50 % of data, the collection stopped because the control reflections were below 50 % of their initial intensity. It is suspected that the crystal changed phase during the data collection (the crystal became completely opaque) and an anhydrous phase was formed. Namely, the structure of this molecule, beside two independent molecules, contains a water molecule. In spite of the poor data and less precisely defined molecular parameters, the revealed structure enabled its energy minimum conformation to be defined by molecular-mechanic calculations (MMS) using PCMODEL program. 9 Diffraction data for compound 4 are given in Table II . Two alternative pathways were employed to obtain 3-hydroxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (5, Scheme 1) from secocyanoalcohol 1. 5 The first procedure 3, 4 comprised the substitution reaction of the secocyanoalcohol 1 with carbon tetrabromide in absolute pyridine, in the presence of triphenylphosphine, followed by hydrogenolysis of the formed 3-benzyloxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (2). In the second pathway, attention was first focused on the synthesis of the tosylate 3, in order to increase its yield. By varying the amount of p-toluenesulphonyl chloride it was found out that the highest yield of compound 3 is obtained using a threefold amount of this reagent w.r.t. the secocyanoalcohol 1. In this way, the yield was increased to 93 % (previously 84 %). The tosylate 3 was then submitted to hydrogenolysis, in order to deprotect its 3-OH group, whereby compound 4 was obtained in 86 % yield. Finally, the tosylate function was substituted with tetrabutylammonium bromide to give the title compound in 72 % yield.
Although the overall yield of the pathway 1®3®4®5 was slightly lower (57.6 %) in comparison with the earlier described one 6 (62.3 %), the optimisation of the procedure for obtaining the tosylate 3 is important, because this compound is also an intermediate in the previous synthesis of 3-hydroxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (5), as well as of other biologically active seco-estratriene derivatives.
Previous attempts to prepare single crystals of compound 2, precursor of 3-hydroxy-17-bromo-16,17-secoestra-1,3,5(10)-triene-16-nitrile (5) failed. However, recently, single crystals of the bromo-derivative 2 were obtained from a more dilute methanol solution and X-ray structural analysis of this compound was completed.
The perspective view of the molecular structure of compound 2 10 is given in Fig. 1 . The bond distances and angles of the molecules are in agreement with those of similar 17-halogen-substituted D-seco steroidal molecules. 11, 12 The puckering 13 and asymmetry parameters 14 reveal the 8b-envelope and 9a, 13b-chair 5 C 2 conformations of the B and C rings, respectively.
The selected torsion angles C 13 -C 14 -C 15 -C 16 and C 14 -C 13 -C 17 -Br (Table  III) show that the 16-nitrile group is b-, while the Br atom is a-oriented. The C 11 -C 10 … C 13 -C 18 non-bonded torsion angle shows that there is a certain twist along the principal axis of the molecule, as a result of the relatively strong influence of the surrounding molecules. The perspective view of the molecular structure of derivative 4 is given in Fig.  2 , while the fractional atomic coordinates for this compound are given in Table IV (the x, y and z coordinates were determined by the S.U.'S. to be of order 0.005, 0.005 and 0.001, respectively). The puckering and asymmetry parameters reveal the 7a,8b-halfchair 3 H 4 and 9a,13b-chair 5 C 2 conformations of the B and C rings, respectively.
The torsion angles C 13 -C 14 -C 15 -C 16 and C 14 -C 13 -C 17 -O 2 (Table V) show that in both molecules of compound 4, the nitrile function is b-, while the 17-bulky substituent is a-oriented (the estimated S.U.'S. for the torsion angles were of the order of 0.1).
Since the starting materials were synthesized from natural estradiol, the absolute stereochemistry of which is known, 15 the X-ray structures are described for the appropriate enantiomer. Molecular-mechanic calculations for all molecules were performed to establish possible changes in the conformation and distances between the functional groups in the molecules free from interactions with surrounding molecules in the crystalline state.
In compound 2 the C 1 -C 10 … C 13 -C 18 non-bonded torsion angle of 91.2°after MMC confirms that the twisting of the molecule was the result of molecule packing.
Furthermore, for compound 4 it was found that minor differences between the conformations, bond distances and angles of the crystallographically independent molecules A and B disappeared after energy minimization.
Examination of the molecules of both compounds with respect to the possible free rotation about single bonds in the different substituents, using the rigid rotor approximation option of the PCMODEL program, showed that the crystals structures correspond to the global minimum energy structures. The distances between the functional groups in the molecules did not show significant changes in the MMC.
Supplementary materials
Cambridge Polaze}i od estrona, dobijen je u nekoliko sintetskih faza 3-benziloksi-17-hidroksi-16,17-sekoestra-1,3,5(10)-trien-16-nitril (1). Ova supstanca je kqu~ni intermedijer u sintezama drugih 17-supstituisanih 16,17-sekoestronskih derivata. Zbog svoje antiestrogene aktivnosti, kao i potpunog odsustva estrogenog efekta, me|u wima se kao najinteresantniji pokazao 3-hidroksi-17-bromo-16,17-sekoestra-1,3,5(10)-trien-16-nitril (5). Stoga smo poku{ali da prona|emo efektivniji put za sintezu ovog jediwewa. Struktura 3-benziloksi-17-bromo-16,17-sekoestra-1,3,5(10)-trien-16-nitrila (jediwewa 2) i 3-hidroksi-17-p-toluolsulfoniloksi-16,17-sekoestra-1,3,5(10)-trien-16-nitrila (jediwewa 4), intermedijera u dva nezavisna sintetska puta za dobijawe derivata 5, potvr|ena je podacima rendgenske strukturne analize. U radu su diskutovani parametri nabirawa i asimetrije, kao i torzioni uglovi molekula 2 i 4, a izvedena su i molekulsko-mehani~ka izra~unavawa za ove molekule. 
